Pseudomonas aeruginosa in the ICU: Prevalence, resistance profile, and antimicrobial consumption
dc.contributor.author | Ribeiro A.C.D.S. | |
dc.contributor.author | Crozatti M.T.L. | |
dc.contributor.author | da Silva A.A. | |
dc.contributor.author | Macedo R.S. | |
dc.contributor.author | Machado A.M.O. | |
dc.contributor.author | Silva A.T.A. | |
dc.date.accessioned | 2024-03-12T23:50:32Z | |
dc.date.available | 2024-03-12T23:50:32Z | |
dc.date.issued | 2020 | |
dc.description.abstract | © 2020, Sociedade Brasileira de Medicina Tropical. All rights reserved.Introduction: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. Methods: Data were obtained from ICUs between 2010 and 2013. Results: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. Conclusions: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial-and multidrug resistance. | |
dc.description.volume | 53 | |
dc.identifier.doi | 10.1590/0037-8682-0498-2018 | |
dc.identifier.issn | 0037-8682 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/35126 | |
dc.relation.ispartof | Revista da Sociedade Brasileira de Medicina Tropical | |
dc.rights | Acesso Aberto | |
dc.subject.otherlanguage | Antimicrobial agents | |
dc.subject.otherlanguage | Drug resistance | |
dc.subject.otherlanguage | Pseudomonas aeruginosa | |
dc.title | Pseudomonas aeruginosa in the ICU: Prevalence, resistance profile, and antimicrobial consumption | |
dc.type | Artigo | |
local.scopus.citations | 15 | |
local.scopus.eid | 2-s2.0-85076930560 | |
local.scopus.subject | Anti-Bacterial Agents | |
local.scopus.subject | Cross Infection | |
local.scopus.subject | Drug Resistance, Multiple, Bacterial | |
local.scopus.subject | Humans | |
local.scopus.subject | Intensive Care Units | |
local.scopus.subject | Microbial Sensitivity Tests | |
local.scopus.subject | Prevalence | |
local.scopus.subject | Pseudomonas aeruginosa | |
local.scopus.subject | Pseudomonas Infections | |
local.scopus.updated | 2024-05-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076930560&origin=inward |